Review
Copyright ©The Author(s) 2017.
World J Gastroenterol. Jun 14, 2017; 23(22): 3978-3998
Published online Jun 14, 2017. doi: 10.3748/wjg.v23.i22.3978
Table 8 Candidate gene studies (low susceptibility genes) in gallbladder cancer
Pathway involvedGenePolymorphismPopulationRef.
DNA repair pathway genesXPC(rs2228000) Ala499ValChina[236]
(rs2228001) Lys939GlnChina
ERCC2(rs1799793) Asp312AsnNorth Indian[232]
(rs13181) Lys751GlnNorth Indian
MSH2(rs2303426) IVS1+9G>C
(rs2303425) -118T>C
OGG1(rs2072668) 748-15C>G
TP53(rs1042522) Pro72ArgChilean, Hungary, Japanese[237-239]
XRCC1(rs1799782) Arg194TrpNorth Indian Shanghai, China[222,231]
(rs25487) Arg399Gln
APEX1(rs3136820) Asp148GluShanghai, China[222]
RAD23B(rs1805335) IVS5-15A>G[223]
(rs1805329) EX7+65C>T
FEN1FEN1-69G>A and haplotypesChina[240]
Hormonal pathway genesCCKAR(rs1800857) IVS1-5T>CNorth Indian[227]
CCK and CCKAR(rs2071011G>C, rs915889C/T, rs3822222C/T, rs1800855T/AShanghai, China,[241]
ESR1(rs2234693) IVS1-397T>CShanghai, China, North India[241-243]
(rs3841686) IVS5-34->T
(rs2228480) Ex8+229G>A
(rs1801132) Ex4-122G>C
(rs9340799) IVS1-351A>G
ESR2(rs1256049) Val328ValShanghai, China
PGRIns/DelNorth India
AR(CAG)nShanghai, China[244]
(rs4633) His62HisShanghai, China[224]
COMT(rs4818) Leu136Leu
CYP1A1(rs2606345) IVS1+606G>T
CYP1B1(rs10012)Arg48Gly
(rs1065778) IVS4-76A>GShanghai, China[224]
CYP19A1(rs700518) Val80Val
(rs2304463) IVS7-106T>G
(rs700519) Arg264Cys
(rs1065779) IVS9-53G>T
(rs4646) Ex11+410G>T
HSD3B2(rs1819698) Ex4-133C>TShanghai, China[224]
(rs1361530) Ex4-88C>G
HSD17B3(rs2066479) Gly289Arg
HSD17B1(rs2830) Ex1-486G>A
SHBG(rs6259) Ex8+6G>A
SRD5A2(rs523349) Ex1-17G>C
RXR-a(rs1536475) IVS6+70A>GShanghai, China[245]
(rs1805343) IVS1-27A>G
RXR-b(rs2744537) G392T
(rs2076310) C51T
INS(rs689) A-6TShanghai, China[245]
PPARD(rs2016520) Ex4+15C>TShanghai, China
PPARG(rs3856806) His477HisShanghai, China
Inflammatory pathway genesCR1(rs2274567) His1208ArgNorth Indian[230]
( rs12144461) Intron 27, HindIII
IL1RN86-bp VNTRNorth Indian[220]
(rs689466) -1195G>A[233]
PTGS2(rs20417) -765G>C
(rs5275) +8473T>CNorth Indian Shanghai, China[233,246]
IL1B(rs16944) -1060T>CShanghai, China north Indian[220,247]
IL10rs1800871)- 7334T>CShanghai[247]
(rs1800872) -6653A>CShanghai
IL-8(rs10805066) IL8 -13985C>GChina[248]
EGF(rs4444903) +61A>GNorth Indian[221]
TGFb1(rs1800469)-509C>TShanghai, north Indian[219,221,247]
TNF-α(rs1800629) -308G>A
IL6(rs1800795) 236C>G)
IL8(rs10805066) -13985C>GChina[248]
MMP-2(rs2285053) -735 C>TNorth Indian[249]
(rs9340799) -1306 C>T
MMP-7(rs11568818) -181 A>G
(rs2250889) P574R
MMP9(rs 17576) R279Q
(rs 17577) R668Q
TIMP2(rs8179090) -418 G>C
Metabolic pathway genesMTHFR(rs1801133) Ala222ValIndian[228]
APOB(rs17240441) 35_43del9Indian[217]
NAT2(rs1799929) NAT2*5AIndian[216]
(rs1799930) NAT2*6B
rs1799931, NAT2*7A
GSTT1Null polymorphismIndian[215]
GSTP1(rs1695) Ile105Val
CYP17(rs743572) Ex1+27T>CShanghai Indian (265)[250,251]
GSTM1Null polymorphismIndian, Chilean Hungary Japanese[215,237,238]
CYP1A1(rs4646903) CYP1A1*2AIndian, Chilean Hungary Japanese[218,237,239]
(rs1048943) Ile462Val (*2C)China, Chilean, Hungary Japanese[224,237-239]
Cyp1a1 cyp1b1CYP1A1-MspI, CYP1A1-Ile462Val, and CYP1B1-Val432LeuIndia[252]
(rs5930) EX10+55G>AShanghai[253]
LDLR(rs6413504) IVS17_42A>GShanghai
(rs14158) EX18+88G>A
LPL(rs263) IVS5-540C>T
ALOX5(rs2029253) IVS3+100G>A
ApoBrs693) Thr2515ThrIndian Chilean[30,217]
ABCG8(rs11887534) Asp19HisNorth Indian Shanghai China[229,254]
CETP(rs708272) TaqIBChilean Shanghai China[30,254]
(rs1800775) -629C>AShanghai China[254]
LRPAP1(rs11267919)752_177_752_176 I 37North Indian Shanghai China[214,254]
CYP7A1(rs3808607) -204 A>CNorth Indian[255]
CYP7A1(rs3824260) -469 T>CNorth Indian
CYP17(rs743572)A/GNorth Indian[250,251]
ApoB(rs676210) Pro2739LeuShanghai[253]
(rs673548) IVS23-79T>C
rs520354) IVS6+360C > T
(rs1367117) Thr98Ile
(rs440446) IVS1+69C>G
CYP2C19(rs4244285) CYP2C19*2,Japanese[256]
(rs4986893) CYP2C19*3
ADRB3(rs4994)A/GNorth Indian[257]
Apoptosis pathwayCASP8(rs3834129) -652 6N ins/delNorth Indian[258]
(rs1045485) Asp302His
(rs3769818 A) IVS12-19 G>A
Nuclear ReceptorsLxr-alpha, BetaLXR-α (rs7120118) and LXR-β (rs35463555 and rs2695121)North Indian[259]
Cancer Stem cell geneCD44CD44 (rs13347) C>T, CD44 (rs353639)A>C, CD44 (rs187116) G>A, CD44 (rs187115) T>CNorth Indian[260]
NANOG, ALCAM, EpCAM, SOX-2, OCT-4, NANOGNANOG (rs11055786)T>C,North Indian[261]
ALCAM (rs1157)G>A
EpCAM (rs1126497)T>C,
SOX-2(rs11915160)A>C
OCT-4 (rs3130932)T>G,
NANOG (rs11055786)T>C
Prostate stem cell antigenPSCA(rs2294008) T/C and rs2978974)India, Japan[262,263]
miRNAhsa-miR-146a(rs2910164) G>CNorth Indian[264]
hsa-mir-196a2(rs11614913) C>T
hsa-mir-499(rs3746444)T>C
miR-27,miR-570,miR-181miR-27a (rs895819)A>G,North Indian population[265]
miR-570(rs4143815)G>C,
miR-181a(rs12537)C>T
GWAS-associated genesDCC(rs7504990)C>TJapan[234]
( rs2229080) C>GNorth Indian[235]
(rs4078288) A>G
(rs7504990) C>T
(rs714) A>G
Wnt signaling pathwaySFRP4, DKK2, DKK3, APC, AXIN-2, Β-CATENIN, GLI-1SFRP4 (rs1802073) G>T,North Indian[266]
DKK2 (rs17037102) C>T
DKK3 (rs3206824) C>T,
APC (rs4595552)A/T
APC ( rs11954856) G>T,
AXIN-2 (rs4791171)C>T
β-CATENIN (rs4135385) A>G,
GLI-1(rs222826) C>G
Other genesKRAScodon 25 Gln25HisEastern India[267]
ACE I/D(rs4646994) 289 bp delNorth Indian[268]
DNMT3B(rs1569686) -579 G>TNorth Indian[269]
TLR2-196-174delNorth Indian[270]
TLR4(rs4986791) Thr399IleNorth Indian
Adrenergic receptors (ADRA)ADRA2A C-1291G, ADRβ3 T190C or Trp64Arg, and ADRβ1 C1165G or Arg389GlyNorth Indian[271]
Death Receptors and their ligands (DR4)DR4 (rs20575, rs20576 and rs6557634), FAS (rs2234767) FASL (rs763110)North Indian
PlCE1(rs2274223) A>G and. (rs7922612) T>CNorth Indian[272]
Vitamin D receptor (VDR)FokI C>TChina[273]